Gerber Kawasaki Wealth & Investment Management’s Boston Scientific BSX Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,430	Closed	-$215K	–	371
2026 Q1	$215K	Buy	3,430 +348	+11%	+$27.8K	0.01%	322
2025 Q4	$294K	Buy	3,082 +139	+5%	+$13.6K	0.01%	285
2025 Q3	$287K	Buy	2,943 +232	+9%	+$24K	0.01%	277
2025 Q2	$291K	Buy	2,711 +99	+4%	+$10K	0.01%	261
2025 Q1	$264K	Buy	2,612 +130	+5%	+$13.1K	0.01%	264
2024 Q4	$222K	Buy	+2,482	New	+$218K	0.01%	264
2021 Q4	–	Sell	-1,500	Closed	-$65K	–	400
2021 Q3	$65K	Buy	+1,500	New	+$66.4K	0.01%	287

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's BSX Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,430 shares — an estimated $215K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in BSX in Q3 2021 and held it in 7 quarters. The position peaked at $294K in Q4 2025. 1,046 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Gerber Kawasaki Wealth & Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Gerber Kawasaki Wealth & Investment Management sold 3,430 Boston Scientific shares in Q2 2026, an estimated $215K.
Gerber Kawasaki Wealth & Investment Management first reported a position in Boston Scientific in Q3 2021 and held it in 7 quarters.
Gerber Kawasaki Wealth & Investment Management's Boston Scientific position peaked at $294K in Q4 2025.
1,046 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.